Brief: Vericel Announces FDA Approval And Commercial Availability Of Maci Arthro
26/08/2024 12:50
Aug 26 (Reuters) - Vericel Corp VCEL.O :
* VERICEL ANNOUNCES FDA APPROVAL AND COMMERCIAL AVAILABILITY
OF
MACI ARTHRO
Source text for Eikon: ID:nGNX7ZKQtg
Further company coverage: VCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook